|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
AFRIK PHARMACEUTICALS PLC
Main Activities: Chemical Manufacturing - Pharmaceutical and Medicine Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name AFRIK PHARMACEUTICALS PLC Headquarters 1 Afrik Rd, Awo-Omamma, Owerri, Imo State, Nigeria ; Owerri; Imo |
Status: Listed Legal Form: Other non-liability limited Operational Status: Operational ISIN CODE : NGAFRIK00008 Financial Auditors: Julie Chienyenwa Dennis & Co. (2010) Incorporation Date: June 26, 1992 Tel: +(234) 83 501 089 |
|
Company Description |
| Afrik Pharmaceuticals PLC is involved in the manufacturing, marketing and production of pharmaceuticals product. The Company also owns a Chemical plant that produces synthetic resins. In addition the company runs thousands of pre-qualified Suppliers Trade Leads, Products & Companies. |
Company Analysis |
| According to the Consolidated - Non-Audited financial statement for the Year of 2010, total net operating revenues decreased with -10.81%, from NGN 45,968 thousands to NGN 41,000 thousands. Operating Results decreased from NGN 2,170 thousands to NGN -2,000 thousands. The results of the period reached NGN -2,000 thousands at the end of the period against NGN 1,937 thousands last year. Return on equity (Net income/Total equity) went from 11.37% to -1.30%, the Return On Asset (Net income / Total Asset) went from 4.57% to -0.99% and the Net Profit Margin (Net Income/Net Sales) went from 4.21% to -4.88% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 31.17% compared to 148.50% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 0.85 to 0.19 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2010 Y (cons) |
2010 Q2C (cons) |
|
 | ||
| Non-Audited | Non-Audited | |
| ||
| WVB Company Financials | WVB Company Financials | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
202,000 |
44,599 |
| ||
Current Assets |
9,000 |
24,420 |
| ||
Total Liabilities |
48,000 |
25,301 |
| ||
Shareholders Equity |
154,000 |
19,298 |
| ||
Current Liabilities |
48,000 |
25,301 |
| ||
| * All the accounts are in NGN. | ||
Income Statement
| ||
Total Operating Revenue |
41,000 |
24,470 |
| ||
Operational Profit (Loss) |
-2,000 |
1,730 |
| ||
Net Profit (Loss) |
-2,000 |
1,532 |
| ||
| * All the accounts are in NGN. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
-0.99% |
3.44% |
| ||
Annualised Return on Assets (ROA) |
-0.99% |
6.88% |
| ||
Return on Equity (ROE) |
-1.3% |
7.94% |
| ||
Annualised Return on Equity (ROE) |
-1.3% |
15.88% |
| ||
Return on Sales (ROS) |
-4.88% |
6.26% |
| ||
Return on Capital |
-1.3% |
7.94% |
| ||
Gross Profit Margin |
-4.88% |
7.07% |
| ||
Operating Profit Margin |
-4.88% |
7.07% |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
20.5x |
2.25x |
| ||
Inventory Turnover |
7.17x |
2.08x |
| ||
Current asset turnover |
4.56x |
1.00x |
| ||
Fixed-asset turnover |
0.21x |
1.21x |
| ||
Asset Turnover |
0.20x |
0.55x |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
-2,000 |
1,730 |
| ||
EBITDA |
-2,000 |
1,730 |
| ||
Enterprise value |
20,449 |
9,849 |
| ||
Enterprise Value / EBITDA |
-10.22 |
5.69 |
| ||
Bookvalue (BV) |
193,000 |
44,599 |
| ||
Net Cash |
-47,000 |
-22,701 |
| Liquidity Ratios | ||
| ||
Current Ratio |
18.75% |
96.52% |
| ||
Quick ratio |
6.25% |
53.24% |
| ||
Doom's day ratio |
2.08% |
10.28% |
| Leverage Ratios | ||
| ||
Leverage ratio |
131.17% |
231.11% |
| ||
Debt to equity |
31.17% |
131.11% |
| ||
Debt to total assets |
23.76% |
56.73% |
| ||
Debt / Enterprise Value |
44.01% |
0% |
| Market ratios | ||
| ||
Market Capitalization/EBITDA |
-6.22 |
7.20 |
| ||
Price/Book Ratio |
0.06 |
0.28 |
| ||
Market Cap / Net cash |
-0.26 |
-0.55 |
| Trend Ratios | ||
| ||
Revenue Trend |
89.19% |
|
| ||
Net Income Trend |
-103.25% |
|
| ||
Operating Income Trend |
-92.17% |
|
| ||
 |